摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-formyl-2-(8-quinolinyl)benzonitrile | 565203-62-5

中文名称
——
中文别名
——
英文名称
4-formyl-2-(8-quinolinyl)benzonitrile
英文别名
4-Formyl-2-(quinolin-8-yl)benzonitrile;4-formyl-2-quinolin-8-ylbenzonitrile
4-formyl-2-(8-quinolinyl)benzonitrile化学式
CAS
565203-62-5
化学式
C17H10N2O
mdl
——
分子量
258.279
InChiKey
VJRPBHKOFDBYPD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    499.8±45.0 °C(Predicted)
  • 密度:
    1.29±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    53.8
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:fc7ae6d20df2dc902067e12f40568943
查看

反应信息

  • 作为反应物:
    描述:
    4-formyl-2-(8-quinolinyl)benzonitrile正丁基锂(1S,2R)-1-苯基-2-(1-吡咯烷基)-1-丙醇 作用下, 生成 、 4-[(R)-hydroxy-(3-methylimidazol-4-yl)methyl]-2-quinolin-8-ylbenzonitrile
    参考文献:
    名称:
    Enantioselective synthesis of the farnesyltransferase inhibitor, A-345665.0
    摘要:
    The stereoselective synthesis of A-345665.0 1, a novel farnesyl transferase inhibitor, is described. The key step involves a stereoselective addition of an imidazolyl Grignard reagent to aldehyde 8 in the presence of an external chiral auxiliary. Crystallization of the product as the dimeric zinc complex 12 facilitates the isolation of product in > 98:2 er. The biaryl linkage is formed by the use of a Suzuki coupling, employing boronic acid 4 prepared by the directed ortho-lithiation of benzonitrile 6. The overall yield for the six step sequence is 21%. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2006.10.008
  • 作为产物:
    描述:
    4-(二乙氧基甲基)苯甲腈 在 palladium diacetate 、 potassium fluoride 、 硼酸三异丙酯 、 2,2,6,6-tetramethylpiperidinyl-lithium 、 2-(二环己基膦基)联苯 作用下, 以 甲醇甲苯 为溶剂, 生成 4-formyl-2-(8-quinolinyl)benzonitrile
    参考文献:
    名称:
    Enantioselective synthesis of the farnesyltransferase inhibitor, A-345665.0
    摘要:
    The stereoselective synthesis of A-345665.0 1, a novel farnesyl transferase inhibitor, is described. The key step involves a stereoselective addition of an imidazolyl Grignard reagent to aldehyde 8 in the presence of an external chiral auxiliary. Crystallization of the product as the dimeric zinc complex 12 facilitates the isolation of product in > 98:2 er. The biaryl linkage is formed by the use of a Suzuki coupling, employing boronic acid 4 prepared by the directed ortho-lithiation of benzonitrile 6. The overall yield for the six step sequence is 21%. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2006.10.008
点击查看最新优质反应信息

文献信息

  • Substituted phenyl farnesyltransferase inhibitors
    申请人:——
    公开号:US20020019527A1
    公开(公告)日:2002-02-14
    Compounds of formula (I) 1 or pharmaceutically acceptable salts thereof, inhibit farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.
    式(I)的化合物或其药学上可接受的盐,抑制法尼基转移酶。公开了制备这些化合物的方法,含有这些化合物的药物组合物,以及使用这些化合物进行治疗的方法。
  • SUBSTITUTED PHENYL FARNESYLTRANSFERASE INHIBITORS
    申请人:Abbott Laboratories
    公开号:EP1276726A2
    公开(公告)日:2003-01-22
  • [EN] SUBSTITUTED PHENYL FARNESYLTRANSFERASE INHIBITORS<br/>[FR] INHIBITEURS DE PHENYLE FARNESYLTRANSFERASE SUBSTITUES
    申请人:ABBOTT LAB
    公开号:WO2001081316A2
    公开(公告)日:2001-11-01
    Compounds of formula (I) or pharmaceutically acceptable salts thereof, inhibit farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.
查看更多